Volume 51, Issue 1, Pages 4-5 (January 2007)
“What is more exciting? The activity of docetaxel in early prostate cancer or the successful collaboration between urologists and medical oncologists to complete a study in early prostate cancer?” The title and the content of this editorial paper by Michael Carducci, published in May 2005 [1], always aroused my enthusiasm and agreement.
Your session will expire in 8 hours requiring you to log in each day to view content.
FEBRUARY 16, 2012